Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Net Cash Flow (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Net Cash Flow for 16 consecutive years, with $14.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 349.13% to $14.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.9 million, a 339.55% increase, with the full-year FY2025 number at $56.9 million, up 339.55% from a year prior.
  • Net Cash Flow was $14.5 million for Q4 2025 at Acadia Healthcare Company, up from -$12.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $48.3 million in Q2 2023 to a low of -$204.1 million in Q1 2021.
  • A 5-year average of -$12.5 million and a median of $173000.0 in 2023 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: plummeted 2775.51% in 2021, then skyrocketed 29647.79% in 2025.
  • Acadia Healthcare Company's Net Cash Flow stood at -$62.5 million in 2021, then skyrocketed by 106.77% to $4.2 million in 2022, then plummeted by 88.61% to $482000.0 in 2023, then tumbled by 1311.62% to -$5.8 million in 2024, then skyrocketed by 349.13% to $14.5 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Net Cash Flow are $14.5 million (Q4 2025), -$12.7 million (Q3 2025), and $40.2 million (Q2 2025).